These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6157561)

  • 21. Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data.
    Nakashima JM; Hyde DM; Giri SN
    Am J Pathol; 1986 Sep; 124(3):528-36. PubMed ID: 2429553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis.
    Clark JG; Kuhn C
    Am Rev Respir Dis; 1982 Oct; 126(4):737-9. PubMed ID: 6181726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.
    Thrall RS; McCormick JR; Jack RM; McReynolds RA; Ward PA
    Am J Pathol; 1979 Apr; 95(1):117-30. PubMed ID: 86304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxylation of collagen by lungs of rats administered bleomycin.
    Last JA; Gerriets JE; Armstrong LC; Gelzleichter TR; Reiser KM
    Am J Respir Cell Mol Biol; 1990 Jun; 2(6):543-8. PubMed ID: 1693282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism.
    Phan SH; Thrall RS; Williams C
    Am Rev Respir Dis; 1981 Oct; 124(4):428-34. PubMed ID: 6170243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type V collagen. Quantitation in normal lungs and in lungs of rats with bleomycin-induced pulmonary fibrosis.
    Reiser KM; Last JA
    J Biol Chem; 1983 Jan; 258(1):269-75. PubMed ID: 6184372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
    Zia S; Hyde DM; Giri SN
    Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis.
    Phan SH; Thrall RS; Ward PA
    Am Rev Respir Dis; 1980 Mar; 121(3):501-6. PubMed ID: 6158281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
    Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
    J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and levels of coenzyme Q10 in lung and liver in bleomycin-hamster model of lung fibrosis.
    Giri SN; Graver DF
    Toxicol Lett; 1991 Jan; 55(1):47-53. PubMed ID: 1705369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a bleomycin hamster model of subchronic lung fibrosis.
    Zia S; Hyde DM; Giri SN
    Pathology; 1992 Jul; 24(3):155-63. PubMed ID: 1279506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis.
    Raghow B; Irish P; Kang AH
    J Clin Invest; 1989 Dec; 84(6):1836-42. PubMed ID: 2480367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
    Wang Q; Hyde DM; Gotwals PJ; Giri SN
    Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
    Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
    Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quercetin on bleomycin-induced lung injury: a preliminary study.
    Martinez JA; Ramos SG; Meirelles MS; Verceze AV; Arantes MR; Vannucchi H
    J Bras Pneumol; 2008 Jul; 34(7):445-52. PubMed ID: 18695788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gefitinib inhibits α-smooth muscle actin expression in mice with bleomycin-induced lung fibrosis].
    Li L; Li WF; Cai L; Yuan WF; Huang WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2675-8. PubMed ID: 21177177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
    Ploplis VA; Wilberding J; McLennan L; Liang Z; Cornelissen I; DeFord ME; Rosen ED; Castellino FJ
    Am J Pathol; 2000 Sep; 157(3):703-8. PubMed ID: 10980108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.